Saxagliptin overview: special focus on safety and adverse effects

Saxagliptin overview: special focus on safety and adverse effects

Item
http://www.wikidata.org/entity/Q28278863
Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus.Serum alanine transaminase total bilirubin concentrations predict CYP3A activity as measured by midazolam and 1'-hydroxylation.Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures.Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus.Pharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes.A review of gliptins for 2014.Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes.Saxagliptin for the treatment of diabetes - a focus on safety.Expression of GLP-1 receptor and CD26 in human thyroid C-cells: The association of thyroid C-cell tumorigenesis with incretin-based medicine.Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.
P2860

Saxagliptin overview: special focus on safety and adverse effects

Item
http://www.wikidata.org/entity/Q28278863
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Saxagliptin overview: special focus on safety and adverse effects
@ast
Saxagliptin overview: special focus on safety and adverse effects
@en
Saxagliptin overview: special focus on safety and adverse effects
@nl
type
label
Saxagliptin overview: special focus on safety and adverse effects
@ast
Saxagliptin overview: special focus on safety and adverse effects
@en
Saxagliptin overview: special focus on safety and adverse effects
@nl
prefLabel
Saxagliptin overview: special focus on safety and adverse effects
@ast
Saxagliptin overview: special focus on safety and adverse effects
@en
Saxagliptin overview: special focus on safety and adverse effects
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Saxagliptin overview: special focus on safety and adverse effects
@en
P2093
P2860
P304
P31
P356
10.1517/14740338.2013.741584
P407
P433
P478
P577
P698
P921